LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,511
تعداد دریافت فایل اصل مقاله11,291,306
Katebi, Katayoun, Hassanpour, Shirin, Eslami, Hosein, Salehnia, Fatemeh, Hosseinifard, Hossein. (1401). Effect of Pilocarpine Mouthwash on Salivary Flow Rate in Patients with Xerostomia: A Systematic Review and Meta-Analysis. سامانه مدیریت نشریات علمی, 24(Supplement-March-2023), 76-83. doi: 10.30476/dentjods.2022.94335.1778
Katayoun Katebi; Shirin Hassanpour; Hosein Eslami; Fatemeh Salehnia; Hossein Hosseinifard. "Effect of Pilocarpine Mouthwash on Salivary Flow Rate in Patients with Xerostomia: A Systematic Review and Meta-Analysis". سامانه مدیریت نشریات علمی, 24, Supplement-March-2023, 1401, 76-83. doi: 10.30476/dentjods.2022.94335.1778
Katebi, Katayoun, Hassanpour, Shirin, Eslami, Hosein, Salehnia, Fatemeh, Hosseinifard, Hossein. (1401). 'Effect of Pilocarpine Mouthwash on Salivary Flow Rate in Patients with Xerostomia: A Systematic Review and Meta-Analysis', سامانه مدیریت نشریات علمی, 24(Supplement-March-2023), pp. 76-83. doi: 10.30476/dentjods.2022.94335.1778
Katebi, Katayoun, Hassanpour, Shirin, Eslami, Hosein, Salehnia, Fatemeh, Hosseinifard, Hossein. Effect of Pilocarpine Mouthwash on Salivary Flow Rate in Patients with Xerostomia: A Systematic Review and Meta-Analysis. سامانه مدیریت نشریات علمی, 1401; 24(Supplement-March-2023): 76-83. doi: 10.30476/dentjods.2022.94335.1778

Effect of Pilocarpine Mouthwash on Salivary Flow Rate in Patients with Xerostomia: A Systematic Review and Meta-Analysis

Journal of Dentistry
مقاله 1، دوره 24، Supplement-March-2023 - شماره پیاپی 1، خرداد 2023، صفحه 76-83    اصل مقاله (457.21 K)
نوع مقاله: Systematic Review
شناسه دیجیتال (DOI): 10.30476/dentjods.2022.94335.1778
نویسندگان
Katayoun Katebi* 1؛ Shirin Hassanpour2؛ Hosein Eslami1؛ Fatemeh Salehnia3؛ Hossein Hosseinifard4
1Dept. of Oral and Maxillofacial Medicine, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
2Postgraduate Student, Dept. of Pediatric Dentistry, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
3Research Center for Evidence Based Medicine (RCEB), Tabriz University of Medical Sciences, Tabriz, Iran.
4Research Center for evidence based medicine (RCEBM), Tabriz University of Medical Sciences, Tabriz, Iran.
چکیده
Statement of the Problem: Xerostomia is a subjective sensation of dry mouth considered as a complex state affecting multiple oral functions. Pilocarpine may be a useful medication for the treatment of xerostomia, but its side effects limit its use under certain conditions. Recent studies have focused on the pilocarpine mouthwash as an alternative.
Purpose: We have undertaken this study to review the latest available scientific evidence systematically, concerning the effects of pilocarpine mouthwash on salivary flow rate in patients with xerostomia.
Materials and Method: An electronic search for randomized controlled trials published in English until September 2021 related to pilocarpine mouthwash and salivary flow rate in patients with dry mouth was performed in PubMed/Medline, Web of Science, Google Scholar, Embase, and Scopus. A random-effects meta-analysis was conducted to evaluate the relationship between the groups.
Results: Two papers with 86 patients were selected for the final review based on strict eligibility criteria. According to the results of the meta-analysis, the mean visual analogue scale in the patient treated with pilocarpine mouthwash was 0.88 unit lower than that of the control group in the fourth week follow; however, it was not statistically significant (pooled mean difference=-0.88, 95% CI = (-2.72; 0.95), p= 0.34).
Conclusion: It seems that the use of pilocarpine mouthwash can increase the salivary flow rates; however, no optimal dose and application regimen can currently be suggested due to the high heterogeneity of the data. Regarding the relief of the symptoms using pilocarpine mouthwash, the existing evidence does not support its effectiveness.
کلیدواژه‌ها
Pilocarpine؛ Xerostomia؛ Saliva؛ Mouthwashes
سایر فایل های مرتبط با مقاله
مراجع
  • Navazesh M, Kumar SK. Xerostomia: prevalence, diagnosis and management. Compend Contin Educ Dent. 2009; 30: 326-332.
  • Atkinson JC, Grisius M, Massey W. Salivary hypofunction and xerostomia: diagnosis and treatment. Dent Clin North Am. 2005; 49: 309-326.
  • Hopcraft MS, Tan C. Xerostomia: an update for clinicians. Aust Dent J. 2010; 55: 238-244.
  • Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2015; 11: 45-51.
  • Tanasiewicz M, Hildebrandt T, Obersztyn I. Xerostomia of Various Etiologies: A Review of the Literature. Adv Clin Exp Med. 2016; 25: 199-206.
  • Wick JY. Xerostomia: causes and treatment. Consult Pharm. 2007; 22: 985-992.
  • Wolff A, Fox PC, Porter S, Konttinen YT. Established and novel approaches for the management of hyposalivation and xerostomia. Curr Pharm Des. 2012; 18: 5515-5521.
  • Alsakran*Altamimi M. Update knowledge of dry mouth- a guideline for dentists. Afr Health Sci. 2014; 14: 736-742.
  • Turner MD, Ship JA. Dry Mouth and Its Effects on the Oral Health of Elderly People. J Am Dent Assoc. 2007; 138: S15-S20.
  • Molek M, Florenly F, Lister INE, Wahab TA, Lister C, Fioni F. Xerostomia and hyposalivation in association with oral candidiasis: a systematic review and meta-analysis. Evid Based Dent. 2022 Jan 24. doi: 10.1038/s41 432-021-0210-2.
  • Miranda-Rius J, Brunet-Llobet L, Lahor-Soler E, Farré M. Salivary Secretory Disorders, Inducing Drugs, and Clinical Management. Int J Med Sci. 2015; 12: 811-824.
  • Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc. 2003; 134: 61-69.
  • Mese H, Matsuo R. Salivary secretion, taste and hyposalivation. J Oral Rehabil. 2007; 34: 711-723.
  • Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer. 2010; 18: 1061-1079.
  • Napenas JJ, Brennan MT, Fox PC. Diagnosis and treatment of xerostomia (dry mouth). Odontology. 2009; 97: 76 -83.
  • Kubbi JR, Reddy LR, Duggi LS, Aitha H. Xerostomia: an overview. J Indian Acad Oral Med Radiol. 2015; 27: 
  • Porter S, Scully C, Hegarty A. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2004; 97: 28-46.
  • Millsop JW, Wang EA, Fazel N. Etiology, evaluation, and management of xerostomia. Clin Dermatol. 2017; 35: 468-476.
  • Chamani G, Zarei MR, Mehrabani M, Nakhaee N, Kalaghchi B, Aghili M, et al. Assessment of systemic effects of ginger on salivation in patients with post-radiotherapy xerostomia. J Oral Health Oral Epidemiol 2017; 6: 130-137.
  • Dalodom S, Lam-Ubol A, Jeanmaneechotechai S, Takamfoo L, Intachai W, Duangchada K, et al. Influence of oral moisturizing jelly as a saliva substitute for the relief of xerostomia in elderly patients with hypertension and diabetes mellitus. Geriatr Nurs. 2016; 37: 101-109.
  • Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med. 2000; 14: 197-203.
  • Makinen KK, Isotupa KP, Kivilompolo T, Makinen PL, Murtomaa S, Petaja J, et al. The effect of polyol-combinant saliva stimulants on S. mutans levels in plaque and saliva of patients with mental retardation. Spec Care Dentist. 2002; 22: 187-193.
  • Nakamura N, Sasano N, Yamashita H, Igaki H, Shiraishi K, Terahara A, et al. Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese. Auris Nasus Larynx. 2009; 36: 310-313.
  • Cheng CQ, Xu H, Liu L, Wang RN, Liu YT, Li J, et al. Efficacy and safety of pilocarpine for radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis. J Am Dent Assoc. 2016; 147: 236-243.
  • Wu CH, Hsieh SC, Lee KL, Yu CL, Li KJ, Lu MC. Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjögren's syndrome in Taiwan—a double-blind, placebo-controlled trial. J Formos Med Assoc. 2006; 105: 796-803.
  • Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, et al. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study. Int J Radiat Oncol Biol Phys. 2008; 70: 14-22.
  • Al Hamad A, Lodi G, Porter S, Fedele S, Mercadante V. Interventions for dry mouth and hyposalivation in Sjögre-
n's syndrome: A systematic review and meta-analysis. Oral Dis. 2019;25: 1027-1047.

  • Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007; 69: 751-760.
  • Gornitsky M, Shenouda G, Sultanem K, Katz H, Hier M, Black M, et al. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 98: 45-52.
  • hitapanarux I, Kamnerdsupaphon P, Tharavichitkul E, Sumitsawan Y, Sittitrai P, Pattarasakulchai T, et al. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial. J Med Assoc Thai. 2008; 91: 1410-1415.
  • Warde P, O'Sullivan B, Aslanidis J, Kroll B, Lockwood G, Waldron J, et al. A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002; 54: 9-13.
  • Farag AM, Holliday C, Cimmino J, Roomian T, Papas A. Comparing the effectiveness and adverse effects of pilocarpine and cevimeline in patients with hyposalivation. Oral Dis. 2019; 25: 1937-1944.
  • Aframian D, Helcer M, Livni D, Robinson S, Markitziu A, Nadler C. Pilocarpine treatment in a mixed cohort of xerostomic patients. Oral Dis. 2007; 13: 88-92.
  • Masters KJ. Pilocarpine treatment of xerostomia induced by psychoactive medications. Am J Psychiatry. 2005; 162: 1023.
  • Theunissen M, Rideaux-Seferina S, Magdelijns FJ, Janssen DJA, van den Beuken-van Everdingen MHJ. Local Oral Pilocarpine Drops for Relieving Xerostomia (Dry Mouth) in the Elderly: A Pilot Study. J Am Med Dir Assoc. 2021; 22: 185-186.
  • Ghods K, Motamed B, Alaee A, Farrokhnia T. Review of Oral Saliva Measurement Standard Methods. J Res Dent Sci. 2021; 18: 150-160.
  • Kim JH, Ahn HJ, Choi JH, Jung DW, Kwon JS. Effect of 0.1% pilocarpine mouthwash on xerostomia: Double-blind, randomised controlled trial. J. Oral Rehabil. 2014; 41: 226-235.
  • Tanigawa T, Yamashita J, Sato T, Shinohara A, Shibata R, Ueda H, et al. Efficacy and safety of pilocarpine mouthwash in elderly patients with xerostomia. Spec Care Dentist. 2015; 35: 164-169.
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339: b2700.
  • Higgins JP, Altman DG, Gotzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343: d5928.
  • Watanabe M, Yamada C, Komagata Y, Kikuchi H, Hosono H, Itagaki F. New low-dose liquid pilocarpine formulation for treating dry mouth in Sjögren’s syndrome: clini-cal efficacy, symptom relief, and improvement in quality of life. J Pharm Health Care Sci. 2018; 4: 1-6.
  • Bernardi R, Perin C, Becker FL, Ramos GZ, Gheno GZ, Lopes LR, et al. Effect of pilocarpine mouthwash on salivary flow. Braz J Med Biol Res. 2002; 35: 105-110.
  • Taweechaisupapong S, Pesee M, Aromdee C, Laopaiboon M, Khunkitti W. Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer. Aust Dent J. 2006; 51: 333-337.
آمار
تعداد مشاهده مقاله: 1,077
تعداد دریافت فایل اصل مقاله: 691


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب